PRE vs. NAUT, KEQU, FEIM, RPID, SEER, AKYA, INTT, MASS, OWLT, and OPTX
Should you be buying Prenetics Global stock or one of its competitors? The main competitors of Prenetics Global include Nautilus Biotechnology (NAUT), Kewaunee Scientific (KEQU), Frequency Electronics (FEIM), Rapid Micro Biosystems (RPID), Seer (SEER), Akoya Biosciences (AKYA), inTEST (INTT), 908 Devices (MASS), Owlet (OWLT), and Syntec Optics (OPTX). These companies are all part of the "measuring and control equipment" industry.
Prenetics Global vs.
Prenetics Global (NASDAQ:PRE) and Nautilus Biotechnology (NASDAQ:NAUT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, community ranking, profitability and media sentiment.
Prenetics Global received 3 more outperform votes than Nautilus Biotechnology when rated by MarketBeat users. Likewise, 87.50% of users gave Prenetics Global an outperform vote while only 19.05% of users gave Nautilus Biotechnology an outperform vote.
Prenetics Global currently has a consensus price target of $9.00, indicating a potential upside of 66.20%. Nautilus Biotechnology has a consensus price target of $3.58, indicating a potential upside of 132.68%. Given Nautilus Biotechnology's higher probable upside, analysts clearly believe Nautilus Biotechnology is more favorable than Prenetics Global.
Nautilus Biotechnology has a net margin of 0.00% compared to Prenetics Global's net margin of -191.73%. Prenetics Global's return on equity of -16.45% beat Nautilus Biotechnology's return on equity.
Prenetics Global has a beta of -0.31, meaning that its share price is 131% less volatile than the S&P 500. Comparatively, Nautilus Biotechnology has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500.
In the previous week, Prenetics Global had 1 more articles in the media than Nautilus Biotechnology. MarketBeat recorded 3 mentions for Prenetics Global and 2 mentions for Nautilus Biotechnology. Prenetics Global's average media sentiment score of 0.43 beat Nautilus Biotechnology's score of 0.00 indicating that Prenetics Global is being referred to more favorably in the media.
25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 50.7% of Nautilus Biotechnology shares are held by institutional investors. 7.8% of Prenetics Global shares are held by insiders. Comparatively, 40.5% of Nautilus Biotechnology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Prenetics Global has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.
Summary
Prenetics Global beats Nautilus Biotechnology on 10 of the 16 factors compared between the two stocks.
Get Prenetics Global News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Prenetics Global Competitors List
Related Companies and Tools
This page (NASDAQ:PRE) was last updated on 2/22/2025 by MarketBeat.com Staff
